Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Keith Mccain

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCollege of Pharmacy, College of Provost
DivisionPoison Control Center
Address6/134E ED II
320 UAMS Campus Dr.
Mail Slot # 522
Little Rock AR 72205
Phone501-686-6161
vCardDownload vCard

    Collapse Research Funds 
    Collapse research activities
    R01-DA039143     Sep 1, 2016 - Aug 30, 2021
    NIH/NIDA
    Synthetic Cannabinoid Toxicity: Role of Biotransformation
    Role: Co-Investigator

    R01DA039143     (PRATHER, PAUL L)May 15, 2016 - Apr 30, 2021
    NIH/NIDA
    Synthetic Cannabinoid Toxicity: Role of Biotransformation
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Bhandari NR, Day KD, Payakachat N, Franks AM, McCain KR, Ragland D. Use and Risk Perception of Electronic Nicotine Delivery Systems and Tobacco in Pregnancy. Womens Health Issues. 2018 May - Jun; 28(3):251-257. PMID: 29588116.
      View in: PubMed
    2. Patton AL, Seely KA, Yarbrough AL, Fantegrossi W, James LP, McCain KR, Fujiwara R, Prather PL, Moran JH, Radominska-Pandya A. Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants. Biochem Biophys Res Commun. 2018 04 06; 498(3):597-602. PMID: 29522717.
      View in: PubMed
    3. Franks AM, Hawes WA, McCain KR, Payakachat N. Electronic cigarette use, knowledge, and perceptions among health professional students. Curr Pharm Teach Learn. 2017 Nov; 9(6):1003-1009. PMID: 29233367.
      View in: PubMed
    4. Seely KA, Patton AL, Moran CL, Womack ML, Prather PL, Fantegrossi WE, Radominska-Pandya A, Endres GW, Channell KB, Smith NH, McCain KR, James LP, Moran JH. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Sci Int. 2013 Dec 10; 233(1-3):416-22. PMID: 24314548.
      View in: PubMed
    5. Fantegrossi WE, McCain KR, Moran JH, Hoffman RS. Not simply synthetic tetrahydrocannabinol. J Pediatr. 2013 Dec; 163(6):1797-8. PMID: 24128645.
      View in: PubMed
    6. Patton AL, Seely KA, Chimalakonda KC, Tran JP, Trass M, Miranda A, Fantegrossi WE, Kennedy PD, Dobrowolski P, Radominska-Pandya A, McCain KR, James LP, Endres GW, Moran JH. Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology. Anal Chem. 2013 Oct 01; 85(19):9390-9. PMID: 23987522.
      View in: PubMed
    7. Patton AL, Chimalakonda KC, Moran CL, McCain KR, Radominska-Pandya A, James LP, Kokes C, Moran JH. K2 toxicity: fatal case of psychiatric complications following AM2201 exposure. J Forensic Sci. 2013 Nov; 58(6):1676-80. PMID: 23822805.
      View in: PubMed
    8. Franks AM, Schmidt JM, McCain KR, Fraer M. Comparison of the effects of energy drink versus caffeine supplementation on indices of 24-hour ambulatory blood pressure. Ann Pharmacother. 2012 Feb; 46(2):192-9. PMID: 22298600.
      View in: PubMed
    9. McCain KR, Sawyer TS, Spiller HA. Evaluation of centrally acting cholinesterase inhibitor exposures in adults. Ann Pharmacother. 2007 Oct; 41(10):1632-7. PMID: 17848422.
      View in: PubMed
    Mccain's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _